Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
- Resource Type
- Article
- Source
- In
Journal of the American Academy of Dermatology July 2024 91(1):64-71 - Subject
- Language
- ISSN
- 0190-9622